![](/img/cover-not-exists.png)
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer
Ellis, Peter M., Leighl, Natasha B., Hirsh, Vera, Reaume, M. Neil, Blais, Normand, Wierzbicki, Rafal, Sadrolhefazi, Behbood, Gu, Yu, Liu, Dan, Pilz, Korinna, Chu, QuincyLanguage:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2015.05.010
Date:
June, 2015
File:
PDF, 761 KB
english, 2015